Corrigendum to “A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial” [Int. Immunopharmacol. 96 (2021) 107743]

Detalles Bibliográficos
Autores principales: Sharma, Alok, Shah, Mili, Lakshmi, Satya, Sane, Hemangi, Captain, Jignasha, Gokulchandran, Nandini, Khubchandani, Pallavi, Pradeep, M.K., Gote, Prakash, Tuppekar, Balaji, Kulkarni, Pooja, Paranjape, Amruta, Pradhan, Radhika, Varghese, Ritu, Kasekar, Sushil, Nair, Vivek, Khanbande, Ummeammara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280341/
https://www.ncbi.nlm.nih.gov/pubmed/34274220
http://dx.doi.org/10.1016/j.intimp.2021.107932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280341/
https://www.ncbi.nlm.nih.gov/pubmed/34274220
http://dx.doi.org/10.1016/j.intimp.2021.107932

Ejemplares similares